Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Clinical Pharmacology and Therapeutics|June 1, 1991
Absence of metabolic effects of the topical carbonic anhydrase inhibitors MK-927 and sezolamide during two-week ocular administration to normal subjectsT Buclin, J Biollaz, E A Lippa, et al.Journal of Ocular Pharmacology|January 1, 1992
Six week safety study of 2% MK-927 administered twice daily to ocular hypertensive volunteersJ B Serle, J Lustgarten, E A Lippa, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|January 1, 1991
Multiple-dose efficacy comparison of the two topical carbonic anhydrase inhibitors sezolamide and MK-927A Bron, E A Lippa, F Gunning, et al.Eye (London, England)|January 1, 1992
Sezolamide: additivity to timolol twice dailyF Gunning, A Béchetoille, E A Lippa, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|January 1, 1991
Multiple-dose, dose-response relationship for the topical carbonic anhydrase inhibitor MK-927E A Lippa, H Aasved, P J Airaksinen, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|April 1, 1992
Dose response and duration of action of dorzolamide, a topical carbonic anhydrase inhibitorE A Lippa, L E Carlson, B Ehinger, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|August 1, 1989
MK-927: a topically effective carbonic anhydrase inhibitor in patientsA M Bron, E A Lippa, H M Hofmann, et al.Ophthalmology|March 1, 1991
MK-507 versus sezolamide. Comparative efficacy of two topically active carbonic anhydrase inhibitorsE A Lippa, J S Schuman, E J Higginbotham, et al.The American Journal of Cardiology|March 1, 1991
Expanded clinical evaluation of lovastatin (EXCEL) study results. II. Assessment of the human lens after 48 weeks of treatment with lovastatinA M Laties, C L Shear, E A Lippa, et al.Pageof 2